Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Cloarec

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pediatric Nephrology (Berlin, Germany)|August 16, 2008
An antenatal hyper-echogenic colon: questionElodie Merieau, Sylvie Cloarec, Jean François Benoist, et al.
Pediatric Nephrology (Berlin, Germany)|October 12, 2002
Plasma therapy in von Willebrand factor protease deficiencyGeorges Deschênes, Agnès Veyradier, Sylvie Cloarec, et al.
Nephrologie & Therapeutique|March 11, 2022
[Kidney injury in children and adolescents with leptospirosis in France]Sarah De Thomasis, Hugues Flodrops, Brigitte Llanas, et al.
Nephrologie & Therapeutique|January 31, 2024
Standardization of the management of rheumatoid purpura nephropathy in the West of France. What are the repercussions on the renal sequelae?Margaux Salmon, Chloé Rousseau, Gwenaëlle Roussey, et al.
Human Molecular Genetics|October 29, 2004
HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitmentElena Barbacci, Angeliki Chalkiadaki, Christelle Masdeu, et al.
Journal of the American Society of Nephrology : JASN|December 14, 2004
Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndromeMarie-Agnès Dragon-Durey, Chantal Loirat, Sylvie Cloarec, et al.
The Journal of Pediatrics|March 18, 2003
Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndromeAgnès Veyradier, Bernadette Obert, Elie Haddad, et al.
Journal of Clinical Pharmacology|February 12, 2010
Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patientsWei Zhao, May Fakhoury, Georges Deschênes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2010
Acute neurological involvement in diarrhea-associated hemolytic uremic syndromeSylvie Nathanson, Thérésa Kwon, Monique Elmaleh, et al.
European Journal of Pediatrics|November 10, 2025
Transient pseudohypoaldosteronism type I in infants with urinary tract infections and/or uropathy: insights from a French multicenter cohortInès Bernhard, Claire Dossier, Laura Bianchi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pediatric Nephrology (Berlin, Germany)|August 16, 2008
An antenatal hyper-echogenic colon: questionElodie Merieau, Sylvie Cloarec, Jean François Benoist, et al.
Pediatric Nephrology (Berlin, Germany)|October 12, 2002
Plasma therapy in von Willebrand factor protease deficiencyGeorges Deschênes, Agnès Veyradier, Sylvie Cloarec, et al.
Nephrologie & Therapeutique|March 11, 2022
[Kidney injury in children and adolescents with leptospirosis in France]Sarah De Thomasis, Hugues Flodrops, Brigitte Llanas, et al.
Nephrologie & Therapeutique|January 31, 2024
Standardization of the management of rheumatoid purpura nephropathy in the West of France. What are the repercussions on the renal sequelae?Margaux Salmon, Chloé Rousseau, Gwenaëlle Roussey, et al.
Human Molecular Genetics|October 29, 2004
HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitmentElena Barbacci, Angeliki Chalkiadaki, Christelle Masdeu, et al.
Journal of the American Society of Nephrology : JASN|December 14, 2004
Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndromeMarie-Agnès Dragon-Durey, Chantal Loirat, Sylvie Cloarec, et al.
The Journal of Pediatrics|March 18, 2003
Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndromeAgnès Veyradier, Bernadette Obert, Elie Haddad, et al.
Journal of Clinical Pharmacology|February 12, 2010
Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patientsWei Zhao, May Fakhoury, Georges Deschênes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2010
Acute neurological involvement in diarrhea-associated hemolytic uremic syndromeSylvie Nathanson, Thérésa Kwon, Monique Elmaleh, et al.
European Journal of Pediatrics|November 10, 2025
Transient pseudohypoaldosteronism type I in infants with urinary tract infections and/or uropathy: insights from a French multicenter cohortInès Bernhard, Claire Dossier, Laura Bianchi, et al.
Pageof 4